Searched for
BIOTECH COMPANY MODERNA
US stocks: US market sinks as bond yields rise, Walmart results disappointThe S&P 500 consumer discretionary sector was one of the biggest drags on the benchmark index, with megacaps including Amazon and Tesla amo...
Global Market: China, Hong Kong stocks rebound as healthcare and tech shares rallyChina and Hong Kong stocks rebounded on Thursday, led by healthcare and technology shares, after a sharp selloff in the previous session. F...
Moderna plans to lay off 10% of workforce to cut costsModerna is set to reduce its global workforce by roughly 10%, aiming for under 5,000 employees by year's end, as it accelerates cost-cuttin...
Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sinkModerna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. MRNA stock, which has los...
Pfizer's $11.6 bn Biohaven buy could spark more biotech dealsThe deal, announced on Tuesday, is the biggest in the sector so far this year and ends a dearth of large acquisitions, which along with cli...
Biological E to hold trials of its Covid vaccine as booster shotChristian Medical College (CMC), Vellore has said that it is conducting a study to test the efficacy of a booster dose on those who have re...
Vaccine tech transfer hard, next six months key in Covid fight, says leading vaccine makersOn Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including e...
Pfizer, Moderna may want indemnity cover before launching vaccine in IndiaThe Indian government on Tuesday had allowed granting emergency licence for vaccines that have been approved by the US, the UK, Europe, Jap...
Ocugen seeks to sell 100 million doses of Bharat Biotech's Covaxin in US in 2021The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the s...
Tata in talks to launch Moderna vaccine in IndiaTata Medical & Diagnostics, a newly formed subsidiary of Tata Sons, is said to have started initial discussions with US company Moderna for...
Serum, Bharat Biotech jointly pledge for smooth vaccine roll out"Adar Poonawala and Krishna Ella, jointly on behalf of the two companies, today communicated their combined intent to develop, manufacture ...
Moderna mania draws bitcoin comparisons while shorts bleedModerna jumped as much as 17% in New York Tuesday. The stock has surged about 73% and added more than $28 billion in market value over the ...
COVID-19: Moderna submits vaccine data to obtain emergency use authorisation"Moderna's data for the emergency use authorisation request for mRNA-1273 has been submitted to the US FDA," Moderna tweeted on Monday.
Will get COVID-19 under control by listening to experts, says Kamala HarrisUS Vice President-elect Kamala Harris said she along with Biden, will curb the effect of the pandemic in the United States by listening to ...
EU says more vaccine deals to come soon as Moderna unveils positive resultsOn Aug. 24 the EU Commission, which conducts talks with vaccine makers on behalf of EU states, said exploratory talks with Moderna had been...
Chinese government-linked hackers 'targeted COVID-19 vaccine firm Moderna'Last week, the U.S. Justice Department made public an indictment of two Chinese nationals accused of spying on the United States, including...
Moderna extends lipids deal to boost COVID-19 vaccine outputModerna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine in a bid to meet in...
Premji has a winner in ModernaWipro founder-chairman Azim Premji owns a minority stake in US biotech company Moderna, which is developing a vaccine that could potentiall...
Wipro founder Azim Premji is an early investor in US firm ModernaWipro founder Azim Premji is an investor in Moderna, the firm that has emerged a frontrunner for Covid vaccine.
This $5 billion startup made its first Cancer vaccine - for just one personNovel cancer drugs often come with six-figure price tags, so success could be lucrative. Numerous companies are chasing a cancer vaccine. O...